×

ANN HEMATOL 2020 10.1007/s00277-020-04008-3
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas
Hur1, JY; Kim, YJ; Yoon, SE; Son, DS; Park, WY; Kim, SJ; Park, D; Kim, WS

ANN HEMATOL 2020 10.1007/s00277-020-04005-6
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
Yoon1, SE; Kim, SJ; Yoon, KH; Koh, Y; Mun, YC; Do, YR; Choi, YS; Yang, DH; Kim, MK; Lee, GW; Suh, C; Ko, YH; Kim, WS

Lancet Haematol 2020
Survival outcomes for extranodal natural-killer T-cell lymphoma
Fox1, CP; Civallero, M; Federico, M; Kim, WS

LASER MED SCI 2020 10.1007/s10103-019-02906-1
Split-face comparison of the picosecond 1064-nm Nd:YAG laser using a microlens array and the quasi-long-pulsed 1064-nm Nd:YAG laser for treatment of photoaging facial wrinkles and pores in Asians
Yim1, S; Lee, YH; Choi, YJ; Kim, WS

ANN HEMATOL 2020 10.1007/s00277-020-04083-6
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study
Yoon1, SE; Eun, Y; Huh, K; Chung, CR; Yoo, IY; Cho, J; Cho, D; Ko, YH; Park, S; Kim, WS; Kim, SJ

CYTOKINE 2020 10.1016/j.cyto.2020.155048
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
Yi1, JH; Yoon, SE; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ

MODERN PATHOL 2020 10.1038/s41379-019-0392-8
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
Cho1, J; Kim, SJ; Park, WY; Kim, J; Woo, J; Kim, G; Yoon, SE; Ko, YH; Kim, WS

Lancet Haematol 2020 10.1016/S2352-3026(19)30283-2
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
Fox1, CP; Civallero, M; Ko, YH; Manni, M; Skrypets, T; Pileri, S; Kim, SJ; Cabrera, ME; Shustov, AR; Chiattone, CS; Horwitz, SM; Dlouhy, I; Spina, M; Hitz, F; Montoto, S; Nagler, A; Martinez, V; De Souza, CA; Fernandez-Alvarez, R; Ballova, V; Gabus, R; Inghirami, G; Federico, M; Kim, WS

CANCER RES TREAT 2020 10.4143/crt.2019.198
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
Kim1, SJ; Yoon, DH; Kim, JS; Kang, HJ; Lee, HW; Eom, HS; Hong, JY; Cho, J; Ko, YH; Huh, J; Yang, WI; Park, WS; Lee, SS; Suh, C; Kim, WS

J HEMATOL ONCOL 2020 10.1186/s13045-020-00855-9
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
Yoon1, DH; Cao, JN; Chen, TY; Izutsu, K; Kim, SJ; Kwong, YL; Lin, TY; Thye, LS; Xu, B; Yang, DH; Kim, WS

BLOOD 2020 10.1182/blood.2019003127
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
Straus1, DJ; Dlugosz-Danecka, M; Alekseev, S; Illes, A; Picardi, M; Lech-Maranda, E; Feldman, T; Smolewski, P; Savage, KJ; Bartlett, NL; Walewski, J; Ramchandren, R; Zinzani, PL; Hutchings, M; Connors, JM; Radford, J; Munoz, J; Kim, WS; Advani, R; Ansell, SM; Younes, A; Miao, H; Liu, R; Fenton, K; Forero-Torres, A; Gallamini, A

BLOOD ADV 2020 10.1182/bloodadvances.2019001114
Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk
Witalis1, M; Chang, J; Zhong, MC; Bouklouch, Y; Panneton, V; Li, JN; Buch, T; Kim, SJ; Kim, WS; Ko, YH; Veillette, A; Suh, WK

BMC CANCER 2020 10.1186/s12885-020-6612-2
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma
Cho1, I; Lee, H; Yoon, SE; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ

PSYCHO-ONCOL 2020 10.1002/pon.5265
Impact of fear of cancer recurrence on survival among lymphoma patients
Kim1, SJ; Kang, D; Kim, IR; Yoon, SE; Kim, WS; Butow, PN; Guallar, E; Cho, J

LANCET ONCOL 2020 10.1016/S1470-2045(19)30799-5
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations
Lin1, GW; Xu, CG; Chen, KX; Huang, HQ; Chen, JP; Song, B; Chan, JKC; Li, WY; Liu, WP; Shih, LY; Chuang, WY; Kim, WS; Tan, W; Peng, RJ; Laurensia, Y; Cheah, DMZ; Huang, DC; Cheng, CL; Su, YJ; Tan, SY; Ng, SB; Tang, TPL; Han, K; Wang, VYF; Jia, WH; Pei, Z; Li, YJ; Gao, S; Shi, YY; Hu, ZB; Zhang, FR; Zhang, B; Zeng, YX; Shen, HB; He, L; Ong, CK; Lim, ST; Chanock, S; Kwong, YL; Lin, DX; Rothman, N; Khor, CC; Lan, Q; Bei, JX
외 다수